ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)

por Hayes, Dane A., Kunde, Dale A., Taylor, Robyn L., Pyecroft, Stephen B., Sohal, Sukhwinder Singh, Snow, Elizabeth T.
Publicado 2017

Telomere Dynamics and Homeostasis in a Transmissible Cancer

por Ujvari, Beata, Pearse, Anne-Maree, Taylor, Robyn, Pyecroft, Stephen, Flanagan, Cassandra, Gombert, Sara, Papenfuss, Anthony T., Madsen, Thomas, Belov, Katherine
Publicado 2012

Anthropogenic selection enhances cancer evolution in Tasmanian devil tumours

por Ujvari, Beata, Pearse, Anne-Maree, Swift, Kate, Hodson, Pamela, Hua, Bobby, Pyecroft, Stephen, Taylor, Robyn, Hamede, Rodrigo, Jones, Menna, Belov, Katherine, Madsen, Thomas
Publicado 2014

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease

por Phalen, David N., Frimberger, Angela, Pyecroft, Stephen, Peck, Sarah, Harmsen, Colette, Lola, Suzanneth, de Mello Mattos, Beatriz, Li, Kong M., McLachlan, Andrew J., Moore, Antony
Publicado 2013